VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,789,000 | -13.1% | 46,654 | -27.4% | 1.34% | -9.5% |
| Q4 2021 | $2,059,000 | +23.0% | 64,270 | +13.2% | 1.48% | +13.1% |
| Q3 2021 | $1,674,000 | -1.7% | 56,798 | +13.3% | 1.31% | +12.5% |
| Q2 2021 | $1,703,000 | -19.1% | 50,121 | -22.6% | 1.16% | -28.7% |
| Q1 2021 | $2,105,000 | +5.3% | 64,773 | +16.7% | 1.63% | -12.5% |
| Q4 2020 | $1,999,000 | +38.6% | 55,486 | +50.7% | 1.86% | +13.0% |
| Q3 2020 | $1,442,000 | -10.7% | 36,812 | -16.3% | 1.65% | -28.8% |
| Q2 2020 | $1,614,000 | +48.6% | 44,001 | -6.7% | 2.32% | +19.3% |
| Q1 2020 | $1,086,000 | -70.1% | 47,153 | -62.0% | 1.94% | -40.6% |
| Q4 2019 | $3,636,000 | – | 124,167 | – | 3.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |